Source: s3://data.kl3m.ai/documents/govinfo/USCOURTS/USCOURTS-cand-5_15-cv-01669/USCOURTS-cand-5_15-cv-01669-0/pdf.json

Nature of Suit Code: 365
Nature of Suit: Personal Injury - Product Liability
Cause of Action: 28:1332 Diversity-Product Liability

---

UNITED STATES JUDICIAL PANEL

on

MULTIDISTRICT LITIGATION

IN RE: XARELTO (RIVAROXABAN)

PRODUCTS LIABILITY LITIGATION MDL No. 2592

(SEE ATTACHED SCHEDULE)

CONDITIONAL TRANSFER ORDER (CTO í34)

On December 12, 2014, the Panel transferred 20 civil action(s) to the United States District Court

for the Eastern District of Louisiana for coordinated or consolidated pretrial proceedings pursuant to

28 U.S.C. § 1407. See _F.Supp.2d_ (J.P.M.L. 2014). Since that time, 293 additional action(s) have

been transferred to the Eastern District of Louisiana. With the consent of that court, all such actions

have been assigned to the Honorable Eldon E. Fallon.

It appears that the action(s) on this conditional transfer order involve questions of fact that are

common to the actions previously transferred to the Eastern District of Louisiana and assigned to

Judge Fallon.

Pursuant to Rule 7.1 of the Rules of Procedure of the United States Judicial Panel on Multidistrict

Litigation, the action(s) on the attached schedule are transferred under 28 U.S.C. § 1407 to the

Eastern District of Louisiana for the reasons stated in the order of December 12, 2014, and, with the

consent of that court, assigned to the Honorable Eldon E. Fallon.

This order does not become effective until it is filed in the Office of the Clerk of the United States

District Court for the Eastern District of Louisiana. The transmittal of this order to said Clerk shall

be stayed 7 days from the entry thereof. If any party files a notice of opposition with the Clerk of the

Panel within this 7íday period, the stay will be continued until further order of the Panel.

FOR THE PANEL:

 Jeffery N. Lüthi

Clerk of the Panel

Case MDL No. 2592 Document 356 Filed 04/27/15 Page 1 of 2

Apr 27, 2015

Apr 28 2015

Case 5:15-cv-01669-NC Document 8 Filed 04/28/15 Page 1 of 2
IN RE: XARELTO (RIVAROXABAN)

PRODUCTS LIABILITY LITIGATION MDL No. 2592

SCHEDULE CTOí34 í TAGíALONG ACTIONS

DIST DIV. C.A.NO. CASE CAPTION

ALABAMA NORTHERN

ALN 4 15í00474 Cameron v. Janssen Research & Development LLC et al

CALIFORNIA NORTHERN

CAN 5 15í01669 Sellers et al v. Janssen Research & Development LLC et

al

GEORGIA MIDDLE

GAM 7 15í00030 BINION et al v. JANSSEN RESEARCH &

DEVELOPMENT LLC et al

MISSOURI WESTERN

MOW 4 15í00163 Durig v. Janssen Research & Development LLC et al

Case MDL No. 2592 Document 356 Filed 04/27/15 Page 2 of 2

DW-	

DW-	

DW-	

DW-	

Case 5:15-cv-01669-NC Document 8 Filed 04/28/15 Page 2 of 2